From: Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
Nottingham Prognostic Index Components | |||||||||
---|---|---|---|---|---|---|---|---|---|
Molecular Subtype | Tumour Size Mean ± St. Error | Tumour Grade | Lymph Node Status | ||||||
I | II | III | None | 1 < LNS < 3 | LNS > 3 | ||||
Luminal | 2.92 cm ± 0.105 | 24.1% | 38% | 38% | 43.9% | 26.7% | 29.4% | ||
(N = 302) | (N = 324) | (N = 262) | |||||||
HER-OE | 3.08 cm ± 0.203 | 4.9% | 16.5% | 78.6% | 42.4% | 24.2% | 33.3% | ||
(N = 93) | (N = 103) | (N = 99) | |||||||
Triple Negative (TNBC) | 3.70 cm ± 0.211 | 4.9% | 23.9% | 71.2% | 48.6% | 25% | 26.4% | ||
(N = 155) | (N = 163) | (N = 148) | |||||||
Luminal | P-value* | ||||||||
Statistics | TNBC vs | p < 0.001 | P-value** < 0.0001 | P-value** Not significant | |||||
HER2-OE | P = 0.05 |